Varenicline

BH3 interacting domain death agonist ; Homo sapiens







7 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33735416 A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol. 2021 Oct 1
2 29860057 Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trial. 2018 Aug 1 1
3 21925806 Results of an initial clinical trial of varenicline for the treatment of cocaine dependence. 2012 Feb 1 1
4 19243716 Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. 2009 Jan 2
5 17407636 A double-blind study evaluating the long-term safety of varenicline for smoking cessation. 2007 Apr 1
6 17692719 A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers. 2007 Jun 1
7 17692720 Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. 2007 Jun 7